[
  {
    "date": "2023-12-30",
    "symbol": "ALLR",
    "period": "FY",
    "cash": 166000,
    "otherassetscurrent": 209000,
    "prepaidexpensecurrent": 781000,
    "incometaxesreceivable": 815000,
    "assetscurrent": 1971000,
    "propertyplantandequipmentnet": 20000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 9871000,
    "assets": 11862000,
    "accountspayablecurrent": 8416000,
    "accruedliabilitiescurrent": 1309000,
    "derivativeliabilitiescurrent": 3083000,
    "taxespayablecurrent": 59000,
    "convertiblenotespayablecurrent": 1300000,
    "liabilitiescurrent": 14167000,
    "deferredincometaxliabilitiesnet": 446000,
    "liabilities": 14613000,
    "preferredstockvalue": 1742000,
    "additionalpaidincapital": 90369000,
    "accumulatedothercomprehensiveincomelossnetoftax": -411000,
    "retainedearningsaccumulateddeficit": -94451000,
    "stockholdersequity": -2751000,
    "liabilitiesandstockholdersequity": 11862000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "temporaryequitypreferredstocksharesdesignated": 20000,
    "temporaryequitysharesissued": 1417,
    "temporaryequitysharesoutstanding": 1417,
    "temporaryequitysharesauthorized": 500000,
    "temporaryequityliquidationpreferencepershare": 17540,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharedesignated": 20000,
    "preferredstocksharesissued": 1417,
    "preferredstocksharesoutstanding": 1417,
    "preferredstockliquidationpreference": 17540,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 750000000,
    "commonstocksharesissued": 5886934,
    "commonstocksharesoutstanding": 5886934,
    "researchanddevelopmentexpense": 7103000,
    "generalandadministrativeexpense": 10026000,
    "operatingexpenses": 17129000,
    "operatingincomeloss": -17129000,
    "investmentincomeinterest": 22000,
    "interestexpense": 498000,
    "foreigncurrencytransactiongainlossbeforetax": 133000,
    "fairvalueadjustmentofwarrants": 4189000,
    "lossonmodificationofwarrants": 591000,
    "changeinfairvalueadjustmentofwarrantderivativeliabilities": -10434000,
    "nonoperatingincomeexpense": 5311000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -11818000,
    "incometaxexpensebenefit": 83000,
    "netincomeloss": -11901000,
    "otherpreferredstockdividendsandadjustments": 8392000,
    "preferredstockdividendsincomestatementimpact": 123000,
    "netincomelossavailabletocommonstockholdersbasic": -20416000,
    "earningspersharebasic": -10.26,
    "weightedaveragenumberofsharesoutstandingbasic": 1990748,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 310000,
    "comprehensiveincomenetoftax": -11591000,
    "earningspersharediluted": -10.26,
    "weightedaveragenumberofdilutedsharesoutstanding": 1990748,
    "sharesoutstanding": 1417,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -1377000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -9347,
    "stockissuedduringperiodvalueredemptionofpreferredstock": -2000,
    "stockissuedduringperiodsharesredemptionofpreferredstock": -190786,
    "stockissuedduringperiodvalueissuedforservices": 6815000,
    "stockissuedduringperiodsharesissuedforservices": 250000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 3772000,
    "deemeddividendsonseriesapreferredstock": 123000,
    "stockissuedduringperiodvalueeliminationofseriesaredemptionrights": -624000,
    "stockissuedduringperiodshareseliminationofredemptionrightsinshares": -4239,
    "stockissuedduringperiodvalueissuanceofapreferredstockasrepaymentofdebt": 453000,
    "stockissuedduringperiodsharesissuanceofpreferredstockasrepaymentofdebt": 486,
    "deemeddividendonredemptionofcancellationfinancing": -1445000,
    "stockissuedduringperiodsharesdeemeddividendonredemptionofpreferredstockandcancellationofdebtinconjuncti": -1550,
    "deemeddividendsofpreferredstock": -1447000,
    "stockissuedperiodsharesdeemeddividendonexchangeofseriescpreferredstockforseriesapreferredstockinshares": -50000,
    "stockredeemedorcalledduringperiodvalue": 206000,
    "stockissuedduringperiodvalueother": 10080000,
    "stockissuedduringperiodsharesother": 2444445,
    "adjustmentstoadditionalpaidincapitalmarktomarket": -6254000,
    "deemeddividendonredemptionofconjunctionfinancing": -4474000,
    "stockdividendsshares": -4630,
    "stockissuedduringperiodvaluestockoptionsexercised": 2962000,
    "stockissuedduringperiodsharesstockoptionsexercised": 2438889,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 1056000,
    "stockissuedduringperiodvaluecashlessexerciseofexchangewarrants": 1031000,
    "stockissuedperiodsharescashlessexerciseofexchangewarrants": 500000,
    "deemeddividendonmodificationofpreferredshares": 373000,
    "stockissuedduringperiodvaluenewissues": 1160000,
    "stockissuedduringperiodsharesnewissues": 50000,
    "stockissuedduringperiodvaluestockdividend": -164000,
    "stockissuedduringperiodsharesstocksplits": 351,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 71000,
    "othercomprehensiveincomelossforeigncurrencytranslationadjustmenttax": 310000,
    "deemeddividendpercentage": 0.05,
    "roundcommonsharesissued": "1-for-35",
    "stockholdersequityreversestocksplit": "1-for-40",
    "depreciationandamortization": 37000,
    "sharebasedcompensation": -71000,
    "foreigncurrencytransactiongainlossunrealized": 179000,
    "paidinkindinterest": 464000,
    "othernoncashincomeexpense": -1110000,
    "changeinfairvalueadjustmentofwarrantandderivativeliabilities": -10434000,
    "deferredincometaxexpensebenefit": 97000,
    "increasedecreaseinothercurrentassets": -1350000,
    "increasedecreaseinincometaxesreceivable": 26000,
    "increasedecreaseinprepaidexpense": 190000,
    "increasedecreaseinaccountspayable": 2165000,
    "increasedecreaseinaccruedliabilities": 43000,
    "increasedecreaseinaccruedincometaxespayable": 18000,
    "increasedecreaseinotheroperatingliabilities": -8000,
    "netcashprovidedbyusedinoperatingactivities": -12745000,
    "proceedsfromissuanceofpreferredstockandpreferencestock": 1160000,
    "proceedsfromnotespayable": 1050000,
    "repaymentsofsecureddebt": 3699000,
    "proceedsfromcommonstockandprefundedwarrantissuancenet": 16895000,
    "proceedsfromwarrantsexercisedinconjunctionwithpricewarrantinducement": 2243000,
    "redemptionofseriesapreferredstock": 6652000,
    "redemptionofseriesbpreferredstock": 2000,
    "netcashprovidedbyusedinfinancingactivities": 10995000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -1750000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -113000,
    "cashandcashequivalentsatcarryingvalue": 166000,
    "incometaxespaid": 6000,
    "interestpaidnet": 34000,
    "conversionofstockamountconverted1": 3899000,
    "issuanceofseriesapreferredstockinexchangeforseriescpreferredstock": 5199000,
    "issuanceofseriesapreferredstocktoextinguishpromissorynote": 453000,
    "redemptionofseriesapreferredstockasrepaymentofdebt": 1445000,
    "deemeddividendonseriesapreferredstock": 8392000,
    "deemeddividendonseriescconvertiblepreferredstockandaccretionofseriescpreferredsh": 123000,
    "deemeddividendonexchangeofseriescpreferredstockforseriesapreferredstock": 1031000,
    "accountingacquiredpatentspolicytextblock": "(i) Acquiredpatents",
    "acquiredinprocessresearchanddevelopmentiprdpolicytextblock": "(j) Acquiredin-process research and development (IPR&D)",
    "researchcontractcostsandaccrualspolicytextblock": "(m) Researchcontract costs and accruals",
    "convertibledebtinstrumentspolicytextblock": "(o) Convertibledebt instruments",
    "warrantspolicytextblock": "(p) Warrants",
    "accumulatedothercomprehensivelosspolicytextblock": "(t) Accumulatedother comprehensive loss",
    "scheduleofseriesapreferredstockandexchangewarrantstabletextblock": "Theaccounting for the Series A Preferred Stock and 3i Exchange Warrants is illustrated in the table below:",
    "scheduleofseriescpreferredstocktabletextblock": "Theroll forward of the Series C Preferred Stock as of December 31, 2023, is as follows:",
    "scheduleofcomponentsofnetlossbeforeincometaxestabletextblock": "Thecomponents of net loss before income taxes were as follows:",
    "scheduleoftaxonprofitlossfortheyeartabletextblock": "Tax    on profit/loss for the year:     2023      2022       Current income tax (benefit) expense     $—      $—       Change in deferred tax      83       (1,521)      Adjustment of tax    concerning previous years      —       —       Tax (benefit) expense     $83      $(1,521)",
    "countryofincorporation": "United States",
    "propertyplantandequipmentusefullife": "P5Y",
    "depositsassetscurrent": 56000,
    "salarydeposit": 22000,
    "valueaddedtaxreceivablecurrent": 131000,
    "foreigntranslationadjustment": 322000,
    "accrueddevelopmentcostliability": 114000,
    "accruedinteresttonmilestoneliabilities": 101000,
    "accruedpayrolltaxescurrent": 398000,
    "accruedboardmemberfees": 60000,
    "accruedprofessionalfeescurrent": 150000,
    "accruedauditandlegal": 425000,
    "otheraccruedliabilitiescurrentandnoncurrent": 61000,
    "accruedliabilitiescurrentandnoncurrent": 1309000,
    "convertiblenotespayable": 1300000,
    "debtinstrumentunamortizeddiscountcurrent": 232000,
    "interestexpenselongtermdebt": 51000,
    "convertibledebt": 889000,
    "interestexpenseother": 245000,
    "accretionexpense": 166000,
    "carryingvalueofthesecuredpromissorynotes": 2644000,
    "interestaccretionsecurednotes": 10000,
    "debtinstrumentincreaseaccruedinterest": 33000,
    "interestexpensedebt": 2687000,
    "proceedsfrominterestreceived": 351000,
    "repaymentsofdebt": 351000,
    "numberofsharesvalued": 4239,
    "shareprice": 20.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.051,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": "September 15, 2023",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.56,
    "preferredstocksharessubscribedbutunissuedvalues": 820000,
    "preferredstockconversions": -1377000,
    "eliminationofredemptionrightsonseriesapreferredstock": -624000,
    "temporaryequityaccretiontoredemptionvalueadjustment": 526000,
    "issuanceofpreferredstockasrepaymentofdebt": 453000,
    "exchangesofseriescpreferredstockforseriesapreferredstocks": 5199000,
    "deemeddividendmodification": 206000,
    "cashlessredemptionofexchangewarrantsforcommonshares": -1031000,
    "equityfairvalueadjustment": 1477000,
    "conversionofstocksharesissued1": 9247,
    "eliminationofredemptionrightsdeemeddividend": 3328000,
    "sharessubjecttomandatoryredemptionsettlementtermsnumberofshares": 6180,
    "issuanceofshares": 486,
    "repaymentsofotherdebt": 350000,
    "interestexpensedebtexcludingamortization": 103000,
    "exchangeofshares": 50000,
    "seriesapreferredstock": 5577,
    "exchangewarrants": 5045446,
    "exchangeofcommonshares": 500000,
    "preferredstockdividendratepercentage": 0.18,
    "dividendspreferredstockcash": 1200000,
    "debtdiscountopening": -40000,
    "dividendspreferredstockpaidinkind": 286000,
    "exchangeofseriescpreferredstockforseriesapreferredstockamount": 1446000,
    "exchangeofseriescpreferredstockforseriesapreferredstock": -1446000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 2263000,
    "modificationstofairvalueuponexercise": 592000,
    "fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersoutoflevel3": -1579000,
    "fairvalueperwarrantissuable": 0.44,
    "derivativeliabilitymeasurementinput": 1,
    "timingofliquidityevent": "Q1 - 2024",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 382,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7876,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P4Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 101,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 13996,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm": "P3Y1M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 341,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5320,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P3Y2M4D",
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 2482000,
    "incometaxreconciliationforeignincometaxratedifferential": -73000,
    "effectiveincometaxratereconciliationtaxvalueofderivativewarrants": -1187000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 25000000,
    "incometaxreconciliationtaxcreditsresearch": 798000,
    "incometaxreconciliationotheradjustments": 17000,
    "incometaxreconciliationprioryearincometaxes": 45000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3524000,
    "effectiveincometaxratecontinuingoperations": 0.22,
    "deferredtaxassetpropertyplantandequipment": -25000,
    "deferredtaxassetsgoodwillandintangibleassets": 1405000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 790000,
    "deferredtaxassetsotheraccruals": 16000,
    "deferredtaxassetsoperatinglosscarryforwards": 16952000,
    "deferredtaxassetsgross": 16328000,
    "deferredtaxassetsvaluationallowance": 16774000,
    "deferredtaxliabilities": 446000,
    "incometaxreconciliationchangeinenactedtaxrate": 83000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9540951,
    "warrantsandrightsoutstanding": 2263000,
    "derivativeassetsliabilitiesatfairvaluenet": 820000,
    "derivativefairvalueofderivativenet": -3083000,
    "depreciationestimatedperiod": "P5Y",
    "paymentsforothertaxes": 5500000,
    "taxcreditcarryforwardamount": 800000,
    "debtinstrumentinterestrateeffectivepercentage": 0.05,
    "depositliabilitiesaccruedinterest": 300000,
    "debtinstrumentcurrentliability": 1300000,
    "interestanddebtexpense": 217000,
    "investmentmaturitydate": "2024-01-01",
    "debtinstrumentinterestratestatedpercentage": 0.05,
    "proceedsfromotherdebt": 5000000,
    "financingreceivablepercentpastdue1": 0.35,
    "equitymethodinvestmentownershippercentage": 0.0999,
    "preferredstockconvertibleconversionprice": 30,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1,
    "preferredstocknoparvalue": 1000,
    "paymentsforproceedsfrompreviousacquisition": 1200000,
    "preferredstockredemptionpercentage": 1.25,
    "debtinstrumentconvertibleconversionprice1": 30,
    "newconversionprice": 1,
    "accruedpercentage": 0.18,
    "financingreceivableexcludingaccruedinterestnonaccrualpercentpastdue": 0.18,
    "derivativenetliabilitypositionaggregatefairvalue": 539000,
    "warrantexchangeshares": 4407201,
    "classofwarrantorrightnumberofsecuritiescalledbyeachwarrantorright": 4877778,
    "financingreceivablemodificationtototalfinancingreceivablespercent": 0.1,
    "deemeddividend": 8392000,
    "exchangedeemeddividend": 3959000,
    "preferredstocksharesexercised": 12052,
    "commonstockothersharesoutstanding": 241893,
    "assetsfairvalueadjustment": 3899000,
    "saleofstocknumberofsharesissuedintransaction": 241893,
    "preferredstockredemptionpricepershare": 0.01,
    "expirationoftheallowablepricepercentage": 0.02,
    "partialliquiddamageinterestrate": 0.18,
    "aggregateamount": 600000,
    "fairvalueamount": 5200000,
    "paymentsofstockissuancecosts": 1240000,
    "commonunitauthorized": 750500000,
    "commonunitissued": 750000000,
    "sharesissuedpricepershare": 0.0001,
    "prefundedwarrantsshares": 178267,
    "proceedsfromissuanceofprivateplacement": 2962000000,
    "exchangefortheexercisewarrants": 2438889,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationincrementalcompensationcost": 2962000,
    "financinginterestexpense": 902000,
    "proceedsfromwarrantexercises": 2154000,
    "saleofstockconsiderationreceivedontransaction": 3899000,
    "convertiblepreferredstocksharesissueduponconversion": 9347,
    "partnerscapitalaccountunitssoldinpublicoffering": 71733,
    "proceedsfromissuanceofdebt": 6815000,
    "commonstockcapitalsharesreservedforfutureissuance": 2444445,
    "incrementalcommonsharesattributabletoconversionofpreferredstock": 2438889,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 500000,
    "othersellinggeneralandadministrativeexpense": 47000,
    "otherresearchanddevelopmentexpense": 24000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 72000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P1Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 101,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 845000,
    "accountspayableothercurrent": 3600000,
    "otheraccruedliabilitiescurrent": 101000,
    "maximumobligatedpayment": 94000000,
    "salesmilestonepayment": 50000000,
    "licensedproductsales": 1000000000,
    "annualsalesincreasepercentage": 0.05,
    "paymentsforroyalties": 100000000,
    "considerationextensionpayment": 1000000,
    "milestonepayments": 1000000,
    "cancellationofcompanyliability": 1309000,
    "agreementpayment": 338000,
    "intercompanyagreementsdescription": "Pursuantto the Oncoheroes Agreement the Company is also entitled to tiered royalties on aggregate net product sales (“Sales”) ofbetween 7% and 12% on net sales of products as follows: 7% on Sales less than $100 million; 10% on Sales of greater than $100 millionand less than $200 million; and 12% on Sales greater than $200 million.",
    "broadcasterslicenseagreementcommitmentsdescription": "(i) $100 which has been paid; (ii) $50 within 10 days of execution ofthe fourth amendment which has been paid; (iii) $100 upon completion of a capital raise (paid on July 18, 2023); and (iv) $850 on or beforeMarch 1, 2024. As of the date of this filing, the Company is currently negotiating a fifth amendment to the extend the timeframe of periodicpayments due.",
    "deferredtaxassetsothertaxcarryforwards": 78100000,
    "paymentsforfees": 127000,
    "dilutivesecurities": 2667000,
    "earningspersharedilutedundistributed": 0.1825,
    "maximumamountofdevelopmentmilestones": 27750000,
    "maximumamountofdevelopmentmilestonepaymentsoflicensedproduct": 500000000,
    "maximumamountofsalesmilestonepaymentsoverfirstandsecondtimesales": 1000000000,
    "milestonepayment": 22500000,
    "milestonepaymentsannualsales": 100000000,
    "interestpaymentpercentage": 0.9,
    "outstandingprincipalamountpershare": 0.4476,
    "minorityinterestownershippercentagebyparent": 0.0499,
    "grossproceedspercentage": 1,
    "averageratepercentage": 0.85,
    "outstandingprincipalpercentage": 1.3,
    "securednotepurchaserandholdersoutstandingpercentage": 0.5001,
    "debtcurrent": 250000,
    "amortizationofleaseincentives": 50000,
    "classofwarrantorrightoutstanding": 4407221,
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "ALLARITY THERAPEUTICS, INC.",
    "entitycentralindexkey": 1860657,
    "entityfilenumber": "001-41160",
    "entitytaxidentificationnumber": "87-2147982",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "24 School Street",
    "entityaddressaddressline2": "2nd Floor",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2108,
    "cityareacode": "(401)",
    "localphonenumber": "426-4664",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "ALLR",
    "securityexchangename": "NASDAQ",
    "auditorname": "Wolf & Company, P.C",
    "auditorfirmid": 392,
    "auditorlocation": "Boston, MA"
  },
  {
    "date": "2022-12-30",
    "symbol": "ALLR",
    "period": "FY",
    "cash": 2029000,
    "otherassetscurrent": 1559000,
    "prepaidexpensecurrent": 591000,
    "incometaxreceivable": 789000,
    "assetscurrent": 4968000,
    "propertyplantandequipmentnet": 21000,
    "financeleaserightofuseasset": 6000,
    "intangibleassetsnetexcludinggoodwill": 9549000,
    "assets": 14544000,
    "accountspayablecurrent": 6251000,
    "accruedliabilitiescurrent": 1904000,
    "accruedincometaxescurrent": 41000,
    "operatingleaseliabilitycurrent": 8000,
    "derivativeliabilitiescurrent": 954000,
    "convertibledebtcurrent": 2644000,
    "liabilitiescurrent": 11222000,
    "accumulateddeferredinvestmenttaxcredit": 1083000,
    "deferredincometaxliabilitiesnet": 349000,
    "liabilities": 12654000,
    "convertiblepreferredstock": 2001000,
    "preferredstockvalue": 2000,
    "redeemablenoncontrollinginterestequitypreferredcarryingamount": 2003000,
    "commonstockvalue": 2000,
    "additionalpaidincapital": 83156000,
    "accumulatedothercomprehensiveincomelossnetoftax": -721000,
    "retainedearningsaccumulateddeficit": -82550000,
    "stockholdersequity": -82550000,
    "liabilitiesandstockholdersequity": 14544000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesdesignated": 500000,
    "preferredstocksharesissued": 190786,
    "preferredstocksharesoutstanding": 13586,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesissued": 15897845,
    "commonstocksharesoutstanding": 15897845,
    "researchanddevelopmentexpense": 6930000,
    "impairmentofintangibleassetsindefinitelivedexcludinggoodwill": 17571000,
    "generalandadministrativeexpense": 9962000,
    "operatingexpenses": 34463000,
    "operatingincomeloss": -34463000,
    "proceedsfromsalesofip": -1780000,
    "investmentincomeinterest": 30000,
    "interestsexpense": -223000,
    "gainlossoninvestments": -115000,
    "foreigncurrencytransactiongainlossbeforetax": -913000,
    "liabilitiesfairvalueadjustment": 17125000,
    "penaltyonseriesapreferredstockliability": 800000,
    "nonoperatingincomeexpense": 16884000,
    "incomelossattributabletoparent": -17579000,
    "incometaxexpensebenefit": -1521000,
    "profitloss": -16058000,
    "preferredstockdividendsincomestatementimpact": 1572000,
    "otherpreferredstockdividendsandadjustments": 3421000,
    "netlossattributabletocommonstockholders": -21051000,
    "earningspersharebasic": -2.21,
    "weightedaveragenumberofsharesoutstandingbasic": 9527111,
    "netincomeloss": -16058000,
    "othercomprehensiveincomelossderivativeexcludedcomponentincreasedecreaseafteradjustmentsandtaxparent": -121000,
    "comprehensiveincomenetoftax": -16179000,
    "deemeddividendpercentage1": 0.08,
    "earningspersharediluted": -2.21,
    "weightedaveragenumberofdilutedsharesoutstanding": 9527111,
    "sharesoutstanding": 15897845,
    "stockissuedduringperiodvaluesharebasedcompensation": 1752000,
    "othercomprehensiveincomelossforeigncurrencytranslationadjustmenttax": -121000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 203000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 7801831,
    "floorpriceliability": -3421000,
    "stockissuedduringperiodvalueconversionofunits": 954000,
    "dividendspreferredstock": 1572000,
    "dividendspreferredstockstock": 2000,
    "preferredstockdividendsshares": 190786,
    "netincomelossavailabletocommonstockholdersbasic": -16058000,
    "deemeddividendpercentage": 0.08,
    "gainlossonsaleofinvestments": 1780000,
    "depreciationdepletionandamortization": 60000,
    "assetimpairmentcharges": 17571000,
    "sharebasedcompensation": 1752000,
    "otheroperatingactivitiescashflowstatement": 138000,
    "lossgainoninvestment": -115000,
    "foreigncurrencytransactiongainlossunrealized": -450000,
    "fairvalueadjustmentofwarrants": 374000,
    "fairvalueadjustmentofderivativeliabilities": -17125000,
    "deferredincometaxexpensebenefit": -1612000,
    "increasedecreaseinothercurrentassets": 1077000,
    "increasedecreaseinprepaidexpense": 618000,
    "increasedecreaseinaccountspayable": 6207000,
    "increasedecreaseinaccruedliabilities": -4722000,
    "increasedecreaseinaccruedincometaxespayable": -19000,
    "increasedecreaseinotheroperatingliabilities": -99000,
    "netcashprovidedbyusedinoperatingactivities": -16817000,
    "proceedsfromsaleofpropertyplantandequipment": 809000,
    "paymentstoacquirepropertyplantandequipment": 18000,
    "netcashprovidedbyusedininvestingactivities": 791000,
    "paymentsofdividendspreferredstockandpreferencestock": 1511000,
    "penaltyonseriesapreferredstockliability1": 800000,
    "proceedsfromissuanceofotherlongtermdebt": 1000000,
    "netcashprovidedbyusedinfinancingactivities": -1311000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -17337000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -189000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2029000,
    "incometaxespaid": 12000,
    "interestpaidnet": 85000,
    "gainonsaleofip": 971000,
    "conversionofstockamountconverted1": 1667000,
    "debtconversionconvertedinstrumentamount1": 1157000,
    "deemed8dividendonseriesapreferredshares": 1572000,
    "seriesbpreferredsharedividend": 2000,
    "reclassificationofderivativeliabilitiesrelatedtoconvertedpreferredstock": 954000,
    "percentageofdebthedgedbyinterestratederivatives": 0.08,
    "rightofuseassertsdisclosuretextblock": "6. Operating lease right-of-use assets ",
    "loantextblock": "9. Loan ",
    "preferredstockandcommonstockpurchasewarrantstextblock": "12. Series A Preferred Stock and Common Stock Purchase Warrants  ",
    "licenseanddevelopmentagreementstextblock": "16. License and Development Agreements ",
    "grantspolicytextblock": "(h) Grants ",
    "acquiredpatentpolicytextblock": "(k) Acquired patents ",
    "acquiredinprocessresearchanddevelopmentiprdpolicytextblock": "(l) Acquired in-process research and development (IPR&D) ",
    "rightofuseassetspolicytextblock": "(o) Operating lease right-of-use assets ",
    "milestoneandroyaltyrevenuerecognitionpolicytextblock": "(q) Milestone and royalty revenue recognition ",
    "researchcontractcostsandaccrualspolicytextblock": "(r) Research contract costs and accruals ",
    "researchanddevelopmentincentivesandreceivablepolicytextblock": "(s) Research and development incentives and receivable ",
    "convertiblebebtinstrumentspolicytextblock": "(u) Convertible debt instruments ",
    "warrantspolicytextblock": "(v) Warrants ",
    "accumulatedothercomprehensivelosspolicytextblock": "(y) Accumulated other comprehensive loss ",
    "recentlyissuedaccountingpronouncementspolicypolicytextblock": "(dd) Recently issued accounting pronouncements ",
    "scheduleofdepreciationexpenseisrecognizedusingthestraightlinemethodovertheestimatedusefullivestabletextblock": "                Estimated Useful Economic Life      Leasehold property improvements         Lesser of lease term or useful life      Laboratory equipment         5 years      Furniture and office equipment         3 years   ",
    "scheduleofcommonsharesinlanternpharmainctabletextblock": "            December 31,             2022      2021       Opening balance     $350      $845       Less receipt of sale proceeds, net      (235)      —       Loss recognition      (115)      (495)      Ending balance     $—      $350   ",
    "scheduleofrightofuseofassertstabletextblock": "            As of December 31,       Balance sheet location     2022      2021       Assets:                    Operating lease assets     $6      $86       Liabilities:                      Current operating lease liabilities     $8      $98       Non-current operating lease liabilities      —       9             $8      $107    ",
    "scheduleofindividuallymaterialdevelopmentprojectsinprogresstabletextblock": "            December 31,             2022      2021       Stenoparib     $9,549      $25,407       Dovitinib      —       2,728       Total     $9,549      $28,135   ",
    "convertiblepromissorynotenettabletextblock": "            December 31, 2022      December 31, 2021       Convertible promissory note     $    1,000      $      1,000       Less debt discount, opening      (215)      (263)      Plus, accretion of debt discount, interest expense      53       48       Convertible promissory note, net of discount      838       785       Interest accretion, opening      194       143       Interest accrual, expense      51       51       Convertible promissory note – net, ending balance     $1,083      $979   ",
    "scheduleofderivativewarrantliabilitiesestimatedinitiallyandquarterlybasistabletextblock": "            January 1, 2022 – September 30, 2022*     December 31, 2021       Initial exercise price     $9.05 - $9.91     $        9.91       Stock price on valuation date     $1.10 - $10.75     $10.37       Risk-free rate     1.03% - 4.23%      0.96%      Time to exercise (years)     2.22 - 2.96      2.97       Equity volatility     70% - 114%      70%      Probability of volume failure     93% - 99%      92%      Rounded 10-day average daily volume (in 1,000’s)     $297 - $873     $908    ",
    "scheduleofweightedaverageexercisepricetabletextblock": "            Number of Shares      Weighted  Average  Exercise  Price      Weighted  Average  Contractual  Term (in years)                                   Balance on January 1, 2022      1,174,992      $6.8       4.91       Granted      46,000       1.2       —       Forfeited      (544,042)      7.3       —       Outstanding as of December 31, 2022      676,949       6.55       4.14       Options exercisable at December 31, 2022      380,119       6.46       4.24    ",
    "scheduleofcomponentsofincomelossbeforeincometaxestabletextblock": "            Year ended  December 31,             2022      2021       Denmark     $(25,336)     $(21,250)      Sweden      (3)      (11)      United States      7,760       (5,254)            $(17,579)     $(26,515)   ",
    "scheduleoftaxonprofitlossfortheyeartabletextblock": "      Tax on profit/loss for the year:     2022      2021       Current income tax (benefit) expense     $—      $88       Change in deferred tax      (1,521)      20       Adjustment of tax concerning previous years      —       25       Tax (benefit) expense     $(1,521)     $133    ",
    "propertyplantandequipmentestimatedusefullives": "Lesser of lease term or useful life",
    "propertyplantandequipmentusefullife": 3,
    "depositassets": 51000,
    "salarydeposit": 85000,
    "valueaddedtaxreceivable": 82000,
    "deferredcostscurrent": 81000,
    "deferreddirectorsofficersinsuranceexpense": 1260000,
    "netothercurrentasset": 1559000,
    "proceedsfromsaleofproductiveassets": 235000,
    "marketablesecuritiesgainloss": -115000,
    "increasedecreaseinotheroperatingassets": 6000,
    "operatingleaseliability": 8000,
    "otherintangibleassetsnet": 9549000,
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuemodificationofcontract": -17571000,
    "goodwillforeigncurrencytranslationgainloss": -1015000,
    "otherindefinitelivedintangibleassets": 9549000,
    "developmentcostliability": 964000,
    "accruedpayrolltaxescurrent": 221000,
    "accruedboardmemberfees": 91000,
    "accruedliabilitiesandotherliabilities": 239000,
    "otheraccruedliabilitiescurrentandnoncurrent": 389000,
    "accruedliabilitiescurrentandnoncurrent": 1904000,
    "convertiblenotespayablecurrent": 1000000,
    "debtinstrumentunamortizeddiscountcurrent": 215000,
    "interestexpenselongtermdebt": 53000,
    "convertibledebt": 838000,
    "interestexpenseother": 194000,
    "financinginterestexpense": 51000,
    "derivativefairvalueofderivativenet": 1083000,
    "debtinstrumentcarryingamount": 2667000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": -33000,
    "convertiblenotespayable": 2634000,
    "depositliabilitiesaccruedinterest": 10000,
    "longtermdebt": 2644000,
    "foreigncurrencytransactionlossbeforetax": 3692000,
    "derivativeassetsliabilitiesatfairvaluenet": 17125000,
    "preferredstocksharessubscribedbutunissuedvalue": 17125000,
    "preferredstockconversionsinducements": 202000,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 265000,
    "redeemablepreferredstockdividends": -1572000,
    "conversionofstocksharesissued1": 2936,
    "preferredstockdividendratepercentage": 0.08,
    "derivativecreditriskvaluationadjustmentderivativeliabilities": 374000,
    "changeinfairvalue1": -6227000,
    "amounttransferredtoequity": -954000,
    "fairvalueperwarrantissuable": 0.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 9.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0433,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5,
    "shareprice": 1.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.2022,
    "constructioncontractorliquiditycharacteristic": "March 15, 2023",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpecteddividendrate": 1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 6.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 676949,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.55,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 4.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 46000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 544042,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 4.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 380119,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 4.24,
    "riskfreeinterestrate": "4.09%",
    "foreignratedifferential": -260000,
    "nondeductibleexpensesother": 1000,
    "taxdeductiononexerciseofemployeewarrants": -3597000,
    "specialtaxdeductiononresearchanddevelopmentexpenses": -754000,
    "lossoffsettoresearchanddevelopmentincentives": 609000,
    "otheradjustments": 1000,
    "adjustmentoftaxconcerningpreviousyears": -871000,
    "deferredtaxassetsvaluationallowance": 7044000,
    "effectivetaxrates": -1521000,
    "lossbeforetaxratepercentage": 0.21,
    "netincomelossattributabletoparentdiluted": -17579000,
    "deferredforeignincometaxexpense": -1521000,
    "deferredtaxassetspropertyplantandequipment": 20000,
    "intangibleassetscurrent": 1160000,
    "allocatedsharebasedcompensationexpense": 1152000,
    "otheraccruals": 44000,
    "deferredtaxassetsoperatinglosscarryforwards": 12981000,
    "totaldeferredtaxincomeloss": 12949000,
    "valuationallowance": 13298000,
    "deferredtaxliabilities": 349000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -1521000,
    "netincomelossfromcontinuingoperationsavailabletocommonshareholdersbasic": -21052000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 2695907,
    "seriesaconvertiblepreferredstock": 7406057,
    "debtconversionconvertedinstrumentsharesissued1": 9071430,
    "incrementalcommonsharesattributabletoconversionofdebtsecurities": 19173394,
    "warrantliability": 374000,
    "creditriskderivativeliabilitiesatfairvalue": -374000,
    "aggregatepurchaseprice": 8075824,
    "financialterm": "oneyear",
    "retainedearningsappropriated": 82600000,
    "foreignexchangegainloss": 121000,
    "estimateddepreciationperiod": 5,
    "impairmentofintangibleassetsfinitelived": 17571,
    "accruedliability": 1400,
    "effectiveincometaxratecontinuingoperations": 0.22,
    "paymentsforothertaxes": 5500000,
    "incometaxreconciliationminorityinterestincomeexpense": 25000000,
    "incometaxcreditsandadjustments": 711,
    "saleofstocknumberofsharesissuedintransaction": 8075824,
    "commonstocknoparvalue": 0.0001,
    "exchangeratiodescription": "The “exchange ratio” means the quotient of the number of Allarity A/S ordinary shares outstanding in Allarity A/Sdivided by 50 or 0.02 shares of Delaware Common Stock for each Allarity A/S ordinary share issued and outstanding (as defined in the ReorganizationAgreement), as of immediately prior to the effective time.",
    "otherexpenses": 200000,
    "commonstockshare": 43898,
    "areaofland": 137,
    "rightofuseassetsamount": 145000,
    "operatingleasecost": 104000,
    "intangibleassetsutilizingadiscounted": 0.26,
    "otherassetimpairmentcharges": 3564000,
    "debtinstrumentinterestratestatedpercentage": 0.05,
    "noncreditableupfrontpayment": 1000000,
    "promissorynote": 1000000,
    "interestpayablepercentage": 0.03,
    "interestexpensedebt": 106000,
    "saleleasebacktransactiongrossproceedsfinancingactivities": 5000000,
    "debtinstrumentredemptionpricepercentageofprincipalamountredeemed": 0.35000000000000003,
    "amortizationofdebtdiscountpremium": 34000,
    "interestexpense": 12000,
    "contractualinterest": 10000,
    "debtinstrumentfaceamount": 10100000,
    "financecostamount": -474000,
    "preferredstockconvertibleconversionprice": 9.9061,
    "debtinstrumentconvertiblethresholdpercentageofstockpricetrigger": 1.25,
    "financingreceivableexcludingaccruedinterestnonaccrualpercentpastdue": 0.18,
    "issuanceofwarrantspurchasedshares": 2018958,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 9.9061,
    "fundwarranttermsdescription": "(i)",
    "preferredstocksharesexercised": 6214,
    "commonstockothersharesoutstanding": 7801831,
    "convertiblepreferredstockconvertedtoothersecurities": 954000,
    "registrationpaymentarrangementaccrualcarryingvalue": 800000,
    "sharesofcommonstock": 30000000,
    "sharesofpreferredstock": 200000,
    "preferredstockpershareamountsofpreferreddividendsinarrears": 400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 388017,
    "optionsvalued": 1004000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0046,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 8.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 156025,
    "presentvalueoffutureinsuranceprofitsamortizationexpenserealizedgainloss": 1752000,
    "researchanddevelopmentexpensesoftwareexcludingacquiredinprocesscost": 596000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 1003000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 2.6,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 544042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1328000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateterm": 5,
    "paymentstoacquireinprocessresearchanddevelopment": 12500000,
    "annualsalesincreasepercentage": 0.08,
    "paymentsforroyalties": 30000000,
    "annualsalesincreasepercentageone": 0.12,
    "paymentsforroyaltiesone": 250000000,
    "annualsalesincreasepercentagetwo": 0.11,
    "paymentsforroyaltiestwo": 500000000,
    "annualsalesincreasepercentagethree": 0.15,
    "documentdescription": "In consideration of the extendedtimeframe, and the Company not achieving the minimum patient enrollment, by July 1, 2022, set out in the Second Amendment, the Companyis obligated to pay Eisai an extension payment as follows: ",
    "paymentstoacquireinprocessresearchanddevelopment1": 94000000,
    "salesmilestonepayment": 50000000,
    "licensedproductsales": 1000000000,
    "extensionpayment": 1000000000,
    "distributionmadetolimitedliabilitycompanyllcmembercashdistributionsdeclared": 1309000,
    "companyagreement": 338000,
    "deferredtaxassetsothertaxcarryforwards": 59600000,
    "paymentsforfees": 269000,
    "litigationreserve": 2667000,
    "basicearningspershareproforma": 0.1825,
    "commonunitissued": 14102155,
    "preferredstockconvertibleconversionprice1": 0.26,
    "preferredunitsissued": 10650,
    "preferredunitsoutstanding": 10650,
    "debtinstrumentconvertibleconversionprice": 0.037,
    "expirationoftheallowablepricepercentage": 0.02,
    "partialliquiddamageinterestrate": 0.18,
    "entityregistrantname": "ALLARITY THERAPEUTICS, INC.",
    "tradingsymbol": "ALLR",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1860657,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-41160",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "87-2147982",
    "entityaddressaddressline1": "24 School Street",
    "entityaddressaddressline2": "2nd Floor",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2108,
    "cityareacode": "(401)",
    "localphonenumber": "426-4664",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 392,
    "auditorname": "Wolf & Company, P.C.",
    "auditorlocation": "Boston, MA"
  },
  {
    "date": "2021-12-30",
    "symbol": "ALLR",
    "period": "FY",
    "cash": 19555000,
    "otherassetscurrent": 625000,
    "prepaidexpensecurrent": 36000,
    "incometaxreceivable": 838000,
    "assetscurrent": 21054000,
    "longterminvestments": 350000,
    "propertyplantandequipmentnet": 8000,
    "financeleaserightofuseasset": 86000,
    "intangibleassetsnetexcludinggoodwill": 28135000,
    "assets": 49633000,
    "accountspayablecurrent": 698000,
    "accruedliabilitiescurrent": 8590000,
    "derivativeliabilitiescurrent": 11273000,
    "accruedincometaxescurrent": 60000,
    "operatingleaseliabilitycurrent": 98000,
    "liabilitiescurrent": 20719000,
    "accumulateddeferredinvestmenttaxcredit": 979000,
    "derivativeliabilitiesnoncurrent": 7181000,
    "operatingleaseliabilitynoncurrent": 9000,
    "deferredincometaxliabilitiesnet": 1961000,
    "liabilities": 30849000,
    "convertiblepreferredstock": 632000,
    "commonstockvalue": 810000,
    "additionalpaidincapital": 84434000,
    "accumulatedothercomprehensiveincomelossnetoftax": -600000,
    "retainedearningsaccumulateddeficit": -66492000,
    "stockholdersequity": 18152000,
    "liabilitiesandstockholdersequity": 49633000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 500000,
    "preferredstocksharesissued": 19800,
    "preferredstocksharesoutstanding": 19800,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesissued": 8096014,
    "commonstocksharesoutstanding": 8096014,
    "researchanddevelopmentexpense": 14196000,
    "generalandadministrativeexpense": 12360000,
    "operatingexpenses": 26556000,
    "operatingincomeloss": -26556000,
    "proceedsfromsalesofip": -1005000,
    "interestsexpense": -499000,
    "interestincomeexpensenet": -1347000,
    "gainlossoninvestments": -495000,
    "foreigncurrencytransactiongainlossbeforetax": -95000,
    "liabilitiesfairvalueadjustment": 154000,
    "changeinfairvalueofconvertibledebt": 474000,
    "gainslossesonextinguishmentofdebt": -141000,
    "othernonoperatingincomeexpense": 41000,
    "incomelossattributabletoparent": -26515000,
    "incometaxexpensebenefit": 133000,
    "netincomeloss": -26648000,
    "netlossattributabletocommonstockholders": -26648000,
    "earningspersharebasic": -4.19,
    "weightedaveragenumberofsharesoutstandingbasic": 6358988,
    "profitloss": -26648000,
    "othercomprehensiveincomelossderivativeexcludedcomponentincreasedecreaseafteradjustmentandtaxnoncontrollinginterest1": 1966000,
    "changeinfairvalueattributabletoinstrumentspecificcreditrisk": 9000,
    "othercomprehensiveincomelossderivativeexcludedcomponentincreasedecreaseafteradjustmentsandtaxparent": -28623000,
    "comprehensiveincomenetoftax": -28623000,
    "sharesoutstanding": 8096014,
    "unitsissuedforcash": 12125000,
    "unitsissuedforcashshares": 2417824,
    "stockissuedduringperiodvaluesharesissuedforcashexerciseofwarrants": 2972000,
    "stockissuedduringperiodsharessharesissuedforcashexerciseofwarrantsinshares": 295537,
    "stockissuedduringfairvalueofinvestorwarrants": -2000000,
    "convertibledebtconversionanddebtsettlement": 2880000,
    "convertibledebtconversionanddebtsettlementinshares": 628192,
    "stockissuedduringperiodvalueissuedforservices": 2384000,
    "stockissuedduringperiodsharesissuedforservices": 482250,
    "stockissuedduringperiodvalueother": -2475000,
    "stockissuedduringperiodvaluesharebasedcompensation": 6368000,
    "othercomprehensiveincomelossforeigncurrencytranslationadjustmenttax": -1966000,
    "stockissuedduringperiodfairvalueofinstrumentspecificcreditrisk": -9000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 82000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 20190,
    "netincomelossavailabletocommonstockholdersbasic": -26648000,
    "gainlossonsaleofinvestments": 1000000,
    "depreciationdepletionandamortization": 106000,
    "sharebasedcompensation": 6368000,
    "otheroperatingactivitiescashflowstatement": 238000,
    "amortizationoffinancingcostsanddiscounts": 1347000,
    "lossgainoninvestment": -495000,
    "foreigncurrencytransactiongainlossunrealized": 74000,
    "extinguishmentofdebtgainlossincometax": 141000,
    "fairvalueadjustmentofwarrants": 474000,
    "fairvalueadjustmentofderivativeliabilities": -2087000,
    "deferredincometaxexpensebenefit": 20000,
    "increasedecreaseinothercurrentassets": 330000,
    "increasedecreaseinprepaidexpense": -130000,
    "increasedecreaseinaccountspayable": -1311000,
    "increasedecreaseinaccruedincometaxespayable": 8000,
    "increasedecreaseinaccruedliabilities": 7197000,
    "increasedecreaseinotheroperatingliabilities": -124000,
    "netcashprovidedbyusedinoperatingactivities": -15050000,
    "proceedsfromsaleofpropertyplantandequipment": 1000000,
    "netcashprovidedbyusedininvestingactivities": 1000000,
    "proceedsfromrepaymentsoflinesofcredit": -84000,
    "proceedsfromissuanceofcommonstock": 32125000,
    "proceedsfromwarrantexercises": 2765000,
    "paymentsofstockissuancecosts": 484000,
    "proceedsfromissuanceofconvertiblepreferredstock": -1557000,
    "proceedsfromissuanceofotherlongtermdebt": 1140000,
    "proceedsfromotherdebt": 2858000,
    "repaymentsofrelatedpartydebt": 2944000,
    "netcashprovidedbyusedinfinancingactivities": 33819000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 19769000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -512000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 19555000,
    "incometaxespaid": 118000,
    "interestpaidnet": 262000,
    "conversionofconvertibledebttoequity": 2825000,
    "conversionofinvestorwarrants": 206000,
    "stockissued1": 55000,
    "debtconversionconvertedinstrumentamount1": 82000,
    "noncashderivativewarrantliabilitycosts": 2384000,
    "rightofuseassetmodification": 145000,
    "rightofuseassertsdisclosuretextblock": "9. Operating lease right-of-use assets ",
    "lineofcreditdisclosuretextblock": "11. Line of credit ",
    "loantextblock": "13. Loan ",
    "preferredstockandcommonstockpurchasewarrantstextblock": "16. Series A PreferredStock and Common Stock Purchase Warrants ",
    "licenseanddevelopmentagreementstextblock": "20. License and Development Agreements ",
    "grantspolicytextblock": "(h) Grants ",
    "noncontrollinginterestpolicytextblock": "(k) Non-controlling interest ",
    "acquiredpatentpolicytextblock": "(l) Acquired Patents ",
    "acquiredinprocessresearchanddevelopmentiprdpolicytextblock": "(m) Acquired In-Process Research and Development (IPR&D) ",
    "rightofuseassetspolicytextblock": "(p) Operating lease right-of-use assets ",
    "milestoneandroyaltyrevenuerecognitionpolicytextblock": "(r) Milestone and royalty revenue recognition ",
    "researchcontractcostsandaccrualspolicytextblock": "(s) Research contract costs and accruals ",
    "researchanddevelopmentincentivesandreceivablepolicytextblock": "(t) Research and development incentives and receivable ",
    "convertiblebebtinstrumentspolicytextblock": "(v) Convertible debt instruments ",
    "warrantspolicytextblock": "(w) Warrants ",
    "accumulatedothercomprehensivelosspolicytextblock": "(z) Accumulated other comprehensive loss ",
    "recentlyissuedaccountingpronouncementspolicytextblock": "(dd) Recently adopted accounting pronouncements ",
    "scheduleofdepreciationexpenseisrecognizedusingthestraightlinemethodovertheestimatedusefullivestabletextblock": "            Estimated Useful Economic Life      Leasehold property improvements     Lesser of lease term or useful life      Laboratory equipment     5 years      Furniture and office equipment     3 years   ",
    "scheduleofcommonsharesinlanternpharmainctabletextblock": "            December 31,             2021$      2020$       Opening balance      845       137       (Loss) gain recognition      (495)      708       Ending balance      350       845   ",
    "scheduleofrightofuseofassertstabletextblock": "            As of December 31,       Balance sheet location     2021      2020       Assets:                    Operating lease assets     $86      $331       Liabilities:                      Current operating lease liabilities     $98      $109       Non-current operating lease liabilities      9       267             $107      $376    ",
    "scheduleofindividuallymaterialdevelopmentprojectsinprogresstabletextblock": "            December 31,             2021$      2020$       Stenoparib      25,407       27,522       Dovitinib      2,728       2,955       Total      28,135       30,477   ",
    "convertiblepromissorynotenettabletextblock": "            December 31, 2021 $      December 31, 2020 (Restated) $       Convertible promissory note      1,000       1,000       Less debt discount, opening      (263)      (306)      Plus, accretion of debt discount, interest expense      48       43       Convertible promissory note, net of discount      785       737       Interest accretion, opening      143       92       Interest accretion, expense      51       51       Ending balance      979       880   ",
    "scheduleofestimatethefairvalueofthewarrantstabletextblock": "            December 20, 2021       Initial exercise price     $9.91       Stock price on valuation date     $10.50       Risk-free rate      0.91%      Expected life of the Warrant to convert (years)      3       Rounded annual volatility      73.0%      Timing of liquidity event      Q3 2022 – Q2 2023       Expected probability of event      90%      Probability of dilutive financing (Down-round)      8.0%   ",
    "scheduleofderivativewarrantliabilitiesestimatedinitiallyandquarterlybasistabletextblock": "            December 21,  2021      December 31,  2021       Base case conversion price     $9.91      $9.91       Stock price on valuation date     $10.50      $10.37       Risk-free rate      0.91%      0.96%      Time to exercise (years)      3.00       2.97       Equity volatility      72.5%      70%      Probability of volume failure      94%      92%      Rounded 10 day average daily volume (in 1,000’s)     $735      $908    ",
    "scheduleofcomponentsofincomelossbeforeincometaxestabletextblock": "            Year ended  December 31,       (in $1,000’s)     2021 $      2020 (Restated)$       Denmark      (21,250)      (6,188)      Sweden      (11)      (4)      United States      (5,254)      (227)             (26,515)      (6,419)   ",
    "scheduleoftaxonprofitlossfortheyeartabletextblock": "      Tax on profit/loss for the year:     2021 $      2020 (Restated) $       Current income tax      88       33       Change in deferred tax      20       165       Adjustment of tax concerning previous years      25       —       Tax received under the tax credit scheme      —       —       Tax expense      133       198    ",
    "propertyplantandequipmentestimatedusefullives": "Lesser of lease term or useful life",
    "propertyplantandequipmentusefullife": 3,
    "deferredtaxliabilities": 1961000,
    "retainedearningsappropriated": 66500000,
    "businessacquisitionsproformanetincomeloss": 699000,
    "increasedecreaseinotheroperatingassets": 86000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 116000,
    "depositassets": 53000,
    "salarydeposit": 65000,
    "valueaddedtaxreceivable": 507000,
    "netothercurrentasset": 625000,
    "prepaidinsurance": 14000,
    "otherprepayments": 22000,
    "prepaidexpensecurrentandnoncurrent": 36000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 350000,
    "marketablesecuritiesgainloss": -495000,
    "leaseholdimprovementsgross": 336000,
    "translationeffects": -328000,
    "totalpropertyequipment": 8000,
    "operatingleaseliability": 107000,
    "operatingleaseweightedaverageremainingleaseterm1": 2,
    "operatingleaseweightedaveragediscountratepercent": 0.1,
    "operatingleasesfutureminimumpaymentsreceivableintwelvemonth": 105000,
    "operatingleasesfutureminimumpaymentsreceivableinyeartwo": 9000,
    "operatingleasesfutureminimumpaymentsreceivabletotal": 114000,
    "imputedinterest": -7000,
    "leasepayment": 107000,
    "finitelivedintangibleassetsgross": 35974000,
    "finitelivedintangibleassetsaccumulatedimpairment": -7761000,
    "finitelivedintangibleassetsaccumulatedamortization": -78000,
    "finitelivedintangibleassetsforeignexchangetranslation": 28135000,
    "otherindefinitelivedintangibleassets": 28135000,
    "developmentcostliability": 6750000,
    "accruedpayrolltaxescurrent": 1088000,
    "accruedboardmemberfees": 54000,
    "accruedliabilitiesandotherliabilities": 316000,
    "otheraccruedliabilitiescurrentandnoncurrent": 382000,
    "accruedliabilitiescurrentandnoncurrent": 8590000,
    "convertiblenotespayablecurrent": 1000000,
    "debtinstrumentunamortizeddiscountcurrent": 263000,
    "interestexpenselongtermdebt": 48000,
    "convertibledebt": 785000,
    "interestexpenseother": 143000,
    "financinginterestexpense": 51000,
    "derivativefairvalueofderivativenet": 979000,
    "convertiblenotespayable": 1140000,
    "servicingliabilityatfairvaluechangesinfairvalueresultingfromchangesinvaluationinputsorchangesinassumptions": 474000,
    "conversionofstockamountissued1": 2825000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 9.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0046,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 9.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9790000000000001,
    "foreigncurrencytransactionlossbeforetax": 5568000,
    "costsallocated": 679000,
    "costsexpensed": 877000,
    "preferredstockconversion": 80000,
    "derivativeassetsliabilitiesatfairvaluenet": -154000,
    "convertiblepreferreddividendsnetoftax": -154000,
    "warrantexercisepricedecrease": 10.37,
    "equitymethodinvestmentownershippercentage": 0.7000000000000001,
    "probabilityofvolumefailure": 0.92,
    "rounded10dayaveragedailyvolumein1000s": 908,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2900074,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.2,
    "stockissuedduringperiodsharesstockoptionsnumberexercised": 274562,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3,
    "stocksissuedduringperiodsharesstockoptionsexercised": -3712271,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 45805,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8,
    "derivativecreditriskvaluationadjustmentderivativeliabilities": 7181000,
    "productwarrantyaccrualwarrantiesissued": 7409000,
    "servicingliabilityatfairvalueotherchangesinfairvalue": -154000,
    "amounttransferredtoequity": -74000,
    "translationeffect": -2000,
    "fairvalueperwarrantissuable": 363,
    "shareprice": 6.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1174992,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1026653,
    "stockissuedduringperiodsharesstockoptionsexercised": 20976,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 45805,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 4.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 568500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 4.76,
    "foreignratedifferential": -210000,
    "nondeductibleexpensessharebasedpayments": 523000,
    "nondeductibleexpensesother": 905000,
    "taxdeductiononexerciseofemployeewarrants": -438000,
    "specialtaxdeductiononresearchanddevelopmentexpenses": -464000,
    "lossoffsettoresearchanddevelopmentincentives": 682000,
    "otheradjustments": 60000,
    "adjustmentoftaxconcerningpreviousyears": 134000,
    "deferredtaxassetsvaluationallowance": 4322000,
    "advertisingbartertransactionsadvertisingbartercosts": 187000,
    "effectivetaxrates": 133000,
    "lossbeforetaxratepercentage": 0.21,
    "netincomelossattributabletoparentdiluted": -26515000,
    "taxespayablecurrent": 113000,
    "deferredforeignincometaxexpense": 20000,
    "deferredtaxassetspropertyplantandequipment": 21000,
    "intangibleassetscurrent": 5198000,
    "allocatedsharebasedcompensationexpense": 815000,
    "otheraccruals": 47000,
    "deferredtaxassetsoperatinglosscarryforwards": 9095000,
    "totaldeferredtaxincomeloss": 4686000,
    "valuationallowance": 6647000,
    "currentincometaxexpensebenefit": 88000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 20000,
    "incometaxreconciliationprioryearincometaxes": 25000,
    "netincomelossfromcontinuingoperationsavailabletocommonshareholdersbasic": -26648000,
    "weightedaveragenumberofdilutedsharesoutstanding": 6358988,
    "earningspersharebasicanddiluted": 4.19,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 3193950,
    "seriesaconvertiblepreferredstock": 1997982,
    "incrementalcommonsharesattributabletoconversionofdebtsecurities": 5191932,
    "assetsheldintrust": 350000,
    "warrantliability": 11273000,
    "preferredstockredemptionamount": 7181000,
    "creditriskderivativeliabilitiesatfairvalue": 18454000,
    "aggregatepurchaseprice": 8075824,
    "financialterm": "one year",
    "foreignexchangegainloss": -1966000,
    "creditriskderivativesatfairvaluenet": -9000,
    "estimateddepreciationperiod": 5,
    "accruedliability": 5000000,
    "effectiveincometaxratecontinuingoperations": 0.22,
    "paymentsforothertaxes": 5500000,
    "incometaxreconciliationminorityinterestincomeexpense": 25000000,
    "incometaxcreditsandadjustments": 875,
    "otherresearchanddevelopmentexpense": 5,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 880000,
    "saleofstocknumberofsharesissuedintransaction": 8075824,
    "commonstocknoparvalue": 0.0001,
    "exchangeratiodescription": "The “exchange ratio” means the quotient of the number of AllarityA/S ordinary shares outstanding in Allarity A/S divided by fifty (50) or 0.02 shares of Delaware Common Stock for each Allarity A/S ordinaryshare issued and outstanding (as defined in the Reorganization Agreement), as of immediately prior to the effective time.",
    "otherexpenses": 200000,
    "commonstockshare": 43898,
    "fairmarketvalue": 350000,
    "depreciation": 12000,
    "areaofland": 137,
    "rightofuseassetsamount": 145000,
    "operatingleasecost": 134000,
    "debtinstrumentinterestratestatedpercentage": 0.05,
    "noncreditableupfrontpayment": 1000000,
    "promissorynote": 1000000,
    "interestpayablepercentage": 0.03,
    "interestanddebtexpense": 99000,
    "guaranteedbenefitliabilitynet": 979000,
    "interestexpensedebt": 99000,
    "percentageofweightedaveragecostinventory": 0.15,
    "creditriskpercentage": 0.01,
    "gainlossonfairvaluehedgesrecognizedinearnings": -9000,
    "financecostamount": -474000,
    "convertiblesubordinateddebtcurrent": 108000,
    "preferredstockconvertibleconversionprice": 9.9061,
    "debtinstrumentconvertibleconversionprice1": 1.25,
    "issuanceofwarrantspurchasedshares": 2018958,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 9.9061,
    "fundwarranttermsdescription": "(i)",
    "assetsundermanagementcarryingamount": 154,
    "issuanceoffairvaluewarrants": 11300000,
    "warrantsofseries": 176,
    "totalproceeds": 6000,
    "warrantsshares": 274386,
    "totalproceed": "$2,679",
    "sharesofcommonstock": 30000000,
    "sharesofpreferredstock": 20000,
    "commonstockdescription": "(a)",
    "commonstockcapitalsharesreservedforfutureissuance": 1211374,
    "optionsvalued": 1004000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0046,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 8.75,
    "optiontopurchasecommonshares": 70477,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 1484,
    "presentvalueoffutureinsuranceprofitsamortizationexpenserealizedgainloss": 6368000,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 4203000,
    "researchanddevelopmentexpensesoftwareexcludingacquiredinprocesscost": 2165000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 4526000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 2.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 4149000,
    "exerciseofstockoptions": 39000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodintrinsicvalue": 418,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 13.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 6.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 4223000,
    "paymentstoacquireinprocessresearchanddevelopment": 12500000,
    "accountspayableandaccruedliabilitiescurrent": 5000,
    "annualsalesincreasepercentage": 0.08,
    "paymentsforroyalties": 30000000,
    "annualsalesincreasepercentageone": 0.12,
    "paymentsforroyaltiesone": 250000000,
    "annualsalesincreasepercentagetwo": 0.11,
    "paymentsforroyaltiestwo": 500000000,
    "annualsalesincreasepercentagethree": 0.15,
    "revenuerecognitionmilestonemethodrevenuerecognized": 50000000,
    "licensedproductsales": 1000000000,
    "extensionpayment": 1000,
    "forgiveninexchangeforapayment": 1264,
    "milestonepaymentsreceived": 16000000,
    "deferredtaxassetsothertaxcarryforwards": 41.6,
    "derivativeliabilities": 7181000,
    "advanceroyalties": 155000,
    "drugdevelopmentprogram": "five",
    "effectiveincometaxratereconciliationdeductionsemployeestockownershipplandividends": 0.18,
    "expirationoftheallowablepricepercentage": 0.02,
    "securitiespurchaseagreementsdescription": "Purchase Price” as defined in the Securities Purchase Agreement which is approximately 2% of $20 million, or $400 and willcontinue to accrue at 2% every 30 days thereafter. Additionally, a late charge of 2% per month will accrue on any payments that are notpaid when due.",
    "entityregistrantname": "ALLARITYTHERAPEUTICS, INC.",
    "tradingsymbol": "ALLR",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1860657,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-41160",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "87-2147982",
    "entityaddressaddressline1": "210 Broadway",
    "entityaddressaddressline2": "Suite 201",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": "(401)",
    "localphonenumber": "426-4664",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 1081,
    "auditorname": "PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab",
    "auditorlocation": "Copenhagen, Denmark"
  }
]